222 related articles for article (PubMed ID: 19015227)
1. Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy.
Sanvito L; Makowska A; Mahdi-Rogers M; Hadden RD; Peakman M; Gregson N; Nemni R; Hughes RA
J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):333-8. PubMed ID: 19015227
[TBL] [Abstract][Full Text] [Related]
2. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
Inglis HR; Csurhes PA; McCombe PA
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):419-22. PubMed ID: 17158557
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to myelin proteins in Guillain-Barré syndrome.
Makowska A; Pritchard J; Sanvito L; Gregson N; Peakman M; Hayday A; Hughes R
J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):664-71. PubMed ID: 17717020
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Khalili-Shirazi A; Atkinson P; Gregson N; Hughes RA
J Neuroimmunol; 1993 Jul; 46(1-2):245-51. PubMed ID: 7689591
[TBL] [Abstract][Full Text] [Related]
6. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
[TBL] [Abstract][Full Text] [Related]
7. Anti-PMP22 antibodies in patients with inflammatory neuropathy.
Gabriel CM; Gregson NA; Hughes RA
J Neuroimmunol; 2000 May; 104(2):139-46. PubMed ID: 10713353
[TBL] [Abstract][Full Text] [Related]
8. Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies.
Kwa MS; van Schaik IN; Brand A; Baas F; Vermeulen M
J Neuroimmunol; 2001 Jun; 116(2):220-5. PubMed ID: 11438177
[TBL] [Abstract][Full Text] [Related]
9. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP.
Staudt M; Diederich JM; Meisel C; Meisel A; Klehmet J
BMC Neurol; 2017 Apr; 17(1):81. PubMed ID: 28446142
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
[TBL] [Abstract][Full Text] [Related]
11. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.
Yan WX; Archelos JJ; Hartung HP; Pollard JD
Ann Neurol; 2001 Sep; 50(3):286-92. PubMed ID: 11558784
[TBL] [Abstract][Full Text] [Related]
12. pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy.
Madia F; Frisullo G; Nociti V; Conte A; Luigetti M; Del Grande A; Patanella AK; Iorio R; Tonali PA; Batocchi AP; Sabatelli M
J Peripher Nerv Syst; 2009 Jun; 14(2):107-17. PubMed ID: 19691533
[TBL] [Abstract][Full Text] [Related]
13. T cell responses to myelin proteins in Guillain-Barré syndrome.
Khalili-Shirazi A; Hughes RA; Brostoff SW; Linington C; Gregson N
J Neurol Sci; 1992 Sep; 111(2):200-3. PubMed ID: 1279128
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
Aranami T; Yamamura T
Nihon Rinsho; 2013 May; 71(5):850-4. PubMed ID: 23777093
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical features of chronic inflammatory demyelinating polyradiculoneuropathy].
Antoine JC
Rev Neurol (Paris); 2006 Apr; 162(4):533-8. PubMed ID: 16585917
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies.
Kwa MS; van Schaik IN; De Jonge RR; Brand A; Kalaydjieva L; van Belzen N; Vermeulen M; Baas F
Brain; 2003 Feb; 126(Pt 2):361-75. PubMed ID: 12538403
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
18. Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy.
Olsson T; Sun JB; Solders G; Xiao BG; Höjeberg B; Ekre HP; Link H
J Neurol Sci; 1993 Jul; 117(1-2):130-9. PubMed ID: 7691993
[TBL] [Abstract][Full Text] [Related]
19. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy.
Vedeler CA; Matre R; Nyland H
Acta Neurol Scand; 1988 Nov; 78(5):401-7. PubMed ID: 2464267
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.
Querol L; Siles AM; Alba-Rovira R; Jáuregui A; Devaux J; Faivre-Sarrailh C; Araque J; Rojas-Garcia R; Diaz-Manera J; Cortés-Vicente E; Nogales-Gadea G; Navas-Madroñal M; Gallardo E; Illa I
Sci Rep; 2017 Oct; 7(1):14411. PubMed ID: 29089585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
